WK2 is an antimicrobial agent that reduces serum TNF-α production induced by bacterial (Bacterial) infections. It is effective in skin wound infection models, where it minimizes wound area and facilitates tissue repair. In pneumonia models, WK2 demonstrates significant anti-inflammatory effects, making it useful for research in bacterial infection-related diseases such as pneumonia.